Is C-Reactive Protein a Specific Marker in Melanoma?

被引：4
作者：
Li, Zhi [1 ]
Feng, Jiexiong [1 ]
Sun, Xiaoyi [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 31期
关键词：
STAGE-IV; SURVIVAL; CANCER; SERUM;
D O I：
10.1200/JCO.2015.62.2696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3673 / +
页数：2
相关论文
共 50 条
  • [41] Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction
    Swiatkiewicz, Iwona
    Kozinski, Marek
    Magielski, Przemyslaw
    Gierach, Joanna
    Fabiszak, Tomasz
    Kubica, Aldona
    Sukiennik, Adam
    Navarese, Eliano Pio
    Odrowaz-Sypniewska, Grazyna
    Kubica, Jacek
    INFLAMMATION RESEARCH, 2012, 61 (07) : 725 - 734
  • [42] Prognostic Significance of C-reactive protein or Prealbumin in Pancreatic Ductal Adenocarcinoma
    Guo, Yu
    Dou, Yibo
    Ma, Xi
    Li, Zhifei
    Li, Haorui
    Sun, Xugang
    Gao, Chuntao
    Liang, Yuexiang
    Zhao, Tiansuo
    JOURNAL OF SURGICAL RESEARCH, 2025, 306 : 543 - 553
  • [43] C-reactive protein and related predictors in soft tissue sarcoma (Review)
    Nakamura, Tomoki
    Asanuma, Kunihiro
    Hagi, Tomohito
    Sudo, Akihiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (01)
  • [44] Thrombosis risk and survival in cancer patients with elevated C-reactive protein
    Kanz, R.
    Vukovich, T.
    Vormittag, R.
    Dunkler, D.
    Ay, C.
    Thaler, J.
    Haselboeck, J.
    Scheithauer, W.
    Zielinski, C.
    Pabinger, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) : 57 - 63
  • [45] Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis
    Hon, Gloudina
    Hassan, Mogamat
    van Rensburg, Susan Janse
    Abel, Stefan
    Marais, De Wet
    van Jaarsveld, Paul
    Smuts, Cornelius
    Henning, Franclo
    Erasmus, Rajiv
    Matsha, Tandi
    BRITISH JOURNAL OF NUTRITION, 2009, 102 (09) : 1334 - 1340
  • [46] Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings
    Amano, Koji
    Maeda, Isseki
    Morita, Tatsuya
    Miura, Tomofumi
    Inoue, Satoshi
    Ikenaga, Masayuki
    Matsumoto, Yoshihisa
    Baba, Mika
    Sekine, Ryuichi
    Yamaguchi, Takashi
    Hirohashi, Takeshi
    Tajima, Tsukasa
    Tatara, Ryohei
    Watanabe, Hiroaki
    Otani, Hiroyuki
    Takigawa, Chizuko
    Matsuda, Yoshinobu
    Nagaoka, Hiroka
    Mori, Masanori
    Kinoshita, Hiroya
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 51 (05) : 860 - 867
  • [47] C-reactive protein : albumin ratio in patients with resectable intrahepatic cholangiocarcinoma
    Matsumoto, T.
    Itoh, S.
    Yoshizumi, T.
    Kurihara, T.
    Yoshiya, S.
    Mano, Y.
    Takeishi, K.
    Harada, N.
    Ikegami, T.
    Soejima, Y.
    Baba, H.
    Mori, M.
    BJS OPEN, 2020, 4 (06): : 1146 - 1152
  • [48] C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients
    Bonazzi, Vanessa F.
    Aoude, Lauren G.
    Brosda, Sandra
    Bradford, Julia J.
    Lonie, James M.
    Loffler, Kelly A.
    Gartside, Michael G.
    Patel, Kalpana
    Mukhopadhyay, Pamela
    Keane, Colm
    Gebski, Val
    Kench, James G.
    Goldstein, David
    Waddell, Nicola
    Barbour, Andrew P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025, 21 (01) : 77 - 86
  • [49] C-reactive protein as an acute phase protein in cancer patients
    Bolayirli, Murat
    Turna, Hande
    Orhanoglu, Timur
    Ozaras, Resat
    Ilhan, Mahmut
    Ozguroglu, Mustafa
    MEDICAL ONCOLOGY, 2007, 24 (03) : 338 - 344
  • [50] C-reactive protein as an acute phase protein in cancer patients
    Murat Bolayırlı
    Hande Turna
    Timur Orhanoğlu
    Resat Ozaras
    Mahmut İlhan
    Mustafa Özgüroğlu
    Medical Oncology, 2007, 24 : 338 - 344
12345